Anxo Pharmaceutical Co Ltd

ROCO:6677 (Taiwan)   Ordinary Shares
NT$ 45.35 (-0.22%) Apr 26
68.19
P/B:
3.07
Market Cap:
NT$ 2.52B ($ 77.43M)
Enterprise V:
NT$ 3.18B ($ 97.63M)
Volume:
90.69K
Avg Vol (2M):
161.69K
Volume:
90.69K
Avg Vol (2M):
161.69K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Anxo Pharmaceutical Co Ltd ( ) from 2018 to Apr 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Anxo Pharmaceutical stock (ROCO:6677) PE ratio as of Apr 28 2024 is 68.19. More Details

Anxo Pharmaceutical Co Ltd (ROCO:6677) PE Ratio (TTM) Chart

To

Anxo Pharmaceutical Co Ltd (ROCO:6677) PE Ratio (TTM) Historical Data

Total 1187
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Anxo Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-28 68.2 2024-02-22 72.0
2024-04-26 68.2 2024-02-21 71.9
2024-04-25 68.3 2024-02-20 72.0
2024-04-24 67.6 2024-02-19 73.1
2024-04-23 66.0 2024-02-16 74.7
2024-04-22 66.2 2024-02-15 74.3
2024-04-19 65.3 2024-02-14 72.1
2024-04-18 65.4 2024-02-13 72.1
2024-04-17 66.2 2024-02-12 72.1
2024-04-16 66.2 2024-02-09 72.1
2024-04-15 66.7 2024-02-08 72.1
2024-04-12 69.5 2024-02-07 72.1
2024-04-11 68.4 2024-02-06 72.1
2024-04-10 66.6 2024-02-05 72.1
2024-04-09 67.0 2024-02-02 71.2
2024-04-08 67.1 2024-02-01 71.6
2024-04-03 65.6 2024-01-31 69.7
2024-04-02 65.5 2024-01-30 69.5
2024-04-01 67.5 2024-01-29 70.5
2024-03-29 67.5 2024-01-26 69.0
2024-03-28 67.9 2024-01-25 68.7
2024-03-27 67.4 2024-01-24 69.0
2024-03-26 68.3 2024-01-23 69.2
2024-03-25 68.9 2024-01-22 69.3
2024-03-22 68.9 2024-01-19 71.2
2024-03-21 69.0 2024-01-18 70.0
2024-03-20 68.5 2024-01-17 71.5
2024-03-19 68.8 2024-01-16 72.9
2024-03-18 69.8 2024-01-15 72.2
2024-03-15 69.6 2024-01-12 72.0
2024-03-14 69.9 2024-01-11 72.8
2024-03-13 69.8 2024-01-10 71.7
2024-03-12 69.2 2024-01-09 72.2
2024-03-11 69.8 2024-01-08 73.6
2024-03-08 70.0 2024-01-05 72.8
2024-03-07 69.7 2024-01-04 72.6
2024-03-06 71.1 2024-01-03 73.1
2024-03-05 72.2 2024-01-02 72.9
2024-03-04 72.3 2024-01-01 72.9
2024-03-01 73.4 2023-12-29 72.9
2024-02-29 73.6 2023-12-28 74.4
2024-02-28 72.7 2023-12-27 72.8
2024-02-27 72.7 2023-12-26 72.9
2024-02-26 73.6 2023-12-25 72.5
2024-02-23 73.5 2023-12-22 74.4

Anxo Pharmaceutical Co Ltd (ROCO:6677) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.